How much does Collective cost? Collective currently advertises compounded semaglutide at $59 per month and compounded tirzepatide at $69 per month, with the medication price described as the same at any dose. A separate $199 annual membership applies after a 21-day membership trial unless the user cancels before the trial ends.

That means the headline $59 or $69 figure is not an all-in monthly program price.

Using the currently advertised amounts as a simple 12-month illustration:

  • 12 months of semaglutide at $59 = $708, plus the $199 annual membership = $907.
  • 12 months of tirzepatide at $69 = $828, plus the $199 annual membership = $1,027.

Those figures are not guaranteed totals. Collective’s Terms also allow a nominal technology transaction fee for each electronic prescription transmission, but the Terms do not publish the amount. Applicable taxes, checkout-specific charges, or future price changes could also affect what a consumer pays.

Affiliate disclosure: Care Path Compare may receive compensation if you use the Collective link and make a purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

Collective pricing at a glance

Cost item Current advertised amount Important detail
Compounded semaglutide $59/month Collective says the medication price stays the same at any dose
Compounded tirzepatide $69/month Collective says the medication price stays the same at any dose
Annual membership $199/year Charged after the 21-day membership trial unless canceled before the trial ends
Membership trial 21 days Medication is not free during the trial; the trial applies to membership
Shipping Described as included Collective advertises express cold shipping
Clinician messaging Described as included with membership Unlimited doctor messaging is advertised
Nutrition/lifestyle support Described as included with membership Program feature, not a guarantee of outcomes
Technology transaction fee Amount not published Terms say CollectiveOS may charge a nominal, uniform fee for each electronic prescription transmission
Insurance billing Not offered Collective describes the program as self-pay
HSA/FSA May qualify Reimbursement depends on the user’s plan administrator

Pricing was rechecked October 1, 2026 and may change.

What the $59 and $69 prices actually represent

Collective’s homepage presents $59 per month for compounded semaglutide and $69 per month for compounded tirzepatide. It also says the medication price remains the same at any dose.

Those are medication prices. Collective separately charges for annual membership after the trial period.

That distinction matters when comparing Collective against programs that bundle medication, clinician care, membership, or support into one monthly number. A fair comparison should use the same cost categories for every provider rather than comparing one company’s medication-only price against another company’s bundled program price.

The $199 annual membership

Collective says the annual membership provides access to member pricing and surrounding program features. Its public materials describe clinician messaging, ongoing check-ins, nutrition and lifestyle support, and express shipping as part of the broader program.

The Terms state that the membership fee is billed annually. The current public site lists that fee at $199 per year.

Because it is billed annually rather than monthly, consumers should distinguish the cash-flow timing from a monthly equivalent. Dividing $199 by 12 gives about $16.58 per month, but Collective does not bill the membership that way; the Terms say the annual amount is charged as an annual membership fee.

How the 21-day trial works

Collective advertises a 21-day membership trial. Its Terms say a trial account automatically converts to a paid annual membership at the end of the trial unless it is canceled beforehand.

The public FAQ says users pay for their medication during the trial. In other words, the trial should not be described as 21 days of free medication.

Before starting, record:

  1. the day the trial begins;
  2. the exact date it ends;
  3. the amount scheduled to be charged for membership;
  4. how to cancel before that charge; and
  5. what happens to medication orders if the membership is canceled.

12-month cost illustration

A useful way to compare Collective is to separate known advertised recurring charges from unconfirmed variable charges.

Compounded semaglutide example

If a user paid the advertised $59 medication price for 12 monthly charges and one $199 annual membership during that period:

$59 × 12 + $199 = $907

That is equivalent to about $75.58 per month when averaged across 12 months, before any applicable technology transaction fee, taxes, or other checkout-specific charges.

Compounded tirzepatide example

If a user paid the advertised $69 medication price for 12 monthly charges and one $199 annual membership:

$69 × 12 + $199 = $1,027

That is equivalent to about $85.58 per month when averaged across 12 months, again before any applicable technology transaction fee, taxes, or other checkout-specific charges.

These calculations are arithmetic examples only. They do not promise that a consumer will remain enrolled for 12 months, qualify for treatment, receive a prescription, stay on a particular medication, or pay the same price in the future.

The technology transaction fee needs confirmation

Collective’s Terms include a pricing detail that is easy to miss.

They state that CollectiveOS may charge a nominal, uniform technology transaction fee for each electronic prescription transmission, regardless of the pharmacy selected. The Terms describe the fee as covering payment-processing and related technology services rather than the clinical decision or prescription itself.

The Terms do not publish the fee amount.

Because the public marketing site also emphasizes simple pricing and “no hidden costs,” consumers should ask Collective to clarify:

  • whether the technology fee currently applies to the GLP-1 program;
  • the exact dollar amount;
  • whether it is charged on an initial prescription, renewal, refill, dose change, or every electronic transmission; and
  • whether it is included in any checkout total shown before payment.

Until that amount is confirmed, we would not call $907 or $1,027 guaranteed all-in annual prices.

Does the price change with dose?

Collective currently says no: its public site advertises the same medication price at any dose for both compounded semaglutide and compounded tirzepatide.

That is a provider pricing claim, not a medical recommendation. Dose selection and changes should be made by the treating clinician based on the individual patient’s circumstances.

Consumers should still save the price shown at checkout and recheck renewal notices because Collective’s Terms allow membership pricing to change in the future with notice.

What happens if the clinician does not prescribe?

Collective’s Terms say a prescription product cannot be processed until a clinician completes a review, determines the medication is clinically appropriate, and issues a valid prescription.

The Terms further state that if a prescription is not issued or the clinical intake is not completed, the order is canceled and the consumer is not charged for the prescription product. Collective’s public FAQ also says a user who is not approved receives a full refund.

However, the Terms contain broader language saying products and services are generally nonrefundable except as CollectiveOS determines. Because medication, membership, and technology fees are distinct charge categories, ask how each would be handled if the clinician does not prescribe.

Cancellation and renewal costs

Collective’s Terms say the annual membership automatically renews until canceled. Cancellation must occur before the end of the then-current membership period to avoid the next annual renewal.

If the membership is canceled after a paid period begins, the account remains active through the end of that billing period. The Terms say membership fees are generally non-refundable and partial-period refunds are not provided except where required by law or expressly stated at purchase.

This makes the 21-day trial deadline especially important: canceling during the trial and canceling after the $199 membership charge are financially different events.

Insurance, HSA, and FSA

Collective says it does not bill insurance. The program is presented as self-pay.

The site says the medication and membership may qualify for HSA/FSA reimbursement. That does not mean every plan will reimburse every charge. Collective itself says reimbursement decisions are made by the plan administrator.

Before using HSA/FSA funds, confirm whether your plan requires documentation such as a receipt, prescription, or letter of medical necessity.

Is shipping included?

Collective advertises express cold shipping as included in the program. The public site does not present a separate standard shipping fee for the current GLP-1 offer.

Still, consumers should confirm how the program handles delayed, damaged, warm, or missing shipments and whether expedited replacement can create a separate charge.

What costs are still not fully disclosed publicly?

The current public pricing leaves several items that a consumer may need to confirm at checkout or with support:

  • the technology transaction fee amount;
  • whether that fee can apply more than once during a treatment cycle;
  • whether any taxes apply to the consumer’s transaction;
  • whether laboratory testing, if a clinician later requires it, creates a separate cost;
  • how each charge is handled if no prescription is issued; and
  • any future renewal-price changes.

That does not mean those charges necessarily apply. It means the public information does not let us calculate a guaranteed all-in total for every user.

How Collective compares on pricing structure

Collective’s pricing model is different from many telehealth programs because it separates a relatively low advertised medication price from a once-yearly membership fee.

That can make the program look substantially cheaper in a headline comparison, but a useful comparison should add all required charges and keep medication categories aligned. In particular, compounded medication should not be presented as the same product as an FDA-approved branded GLP-1 medication.

Use our GLP-1 program price comparison and online GLP-1 program cost guide to compare programs using the same cost framework.

Affiliate disclosure: Care Path Compare may receive compensation if you use the Collective link and make a purchase, at no extra cost to you.

Questions to ask before paying

  1. What is the exact amount I will be charged today?
  2. On what date will the $199 annual membership be charged?
  3. Does the technology transaction fee apply, what is the amount, and how often can it be charged?
  4. Is shipping included for my order and location?
  5. Could lab work or another evaluation create an additional charge?
  6. If a clinician does not prescribe, which charges are canceled or refunded?
  7. What is my annual renewal date and cancellation deadline?
  8. Will the medication price remain the same if the clinician changes the dose?

Bottom line

Collective’s current advertised pricing is straightforward at the medication level: $59/month for compounded semaglutide or $69/month for compounded tirzepatide, plus a $199 annual membership after a 21-day membership trial.

Using 12 advertised monthly medication charges plus one annual membership produces a baseline illustration of $907 for semaglutide or $1,027 for tirzepatide over 12 months. Those are not guaranteed all-in totals because Collective’s Terms allow a separate technology transaction fee whose amount is not publicly stated, and individual circumstances or future pricing can differ.

The most useful checkout question is therefore not just “Is it $59 or $69?” but “What is my complete charge schedule, including membership and any prescription-transaction fee?”

Important information

Official sources

  1. Collective, weight-loss program homepage, accessed October 1, 2026.
  2. CollectiveOS, Terms of Use, version August 12, 2026; accessed October 1, 2026.
  3. U.S. Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, accessed October 1, 2026.